Download | < Back |
13 Sep 2024 | |
Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we would like to inform that a Committee of the Board of Directors of the Company in their meeting held today i.e. September 13, 2024, has inter-alia approved the incorporation of a wholly-owned subsidiary in Pune, Maharashtra, India. | |
View all announcements for Emcure Pharmaceuticals Ltd | Source: BSE India |